Table 2

Clinical factors associated with use (yes vs no) of DANBIO-from-home; results of univariable and multivariable logistic regression analyses with ORs

		Univariate		Multivariate
Covariate		OR (95% CI)	P value	OR (95% CI)	P value
Gender	Male	1 (ref)	0.8	1 (ref)	<0.001
Gender	Female	0.99 (0.95 to 1.04)	0.8	1.19 (1.12 to 1.27)	<0.001
Age, years	<40	1 (ref)		1 (ref)
	40–60	1.66 (1.53 to 1.80)	<0.001	1.79 (1.63 to 1.97)	<0.001
	61–80	1.57 (1.46 to 1.69)	<0.001	1.87 (1.70 to 2.07)	<0.001
	>80	0.39 (0.35 to 0.43)	<0.001	0.57 (0.50 to 0.65)	<0.001
Diagnosis	Rheumatoid arthritis	0.95 (0.89 to 1.15)	0.11	1.08 (0.99 to 1.17)	0.07
	Psoriatic arthritis	1.06 (0.98 to 1.15)	0.12	1.09 (0.99 to 1.20)	0.07
	Axial spondyloarthritis	1 (ref)		1 (ref)
Biological treatment	Yes	1.42 (1.35 to 1.50)	<0.001	1.41 (1.33 to 1.50)	<0.001
Biological treatment	No	1 (ref)	<0.001	1 (ref)	<0.001
Disease duration, years		0.99 (0.99 to 0.99)	<0.001	1.0 (0.99 to 1.00)	0.09
HAQ per unit		0.70 (0.68 to 0.73)	<0.001	0.68 (0.65 to 0.71)	<0.001
PASS	Yes	1 (ref)	<0.001	1 (ref)	0.009
PASS	No	0.89 (0.84 to 0.94)	<0.001	1.09 (1.02 to 1.17)	0.009

Number of patients contributing to analysis: 26 041 (77%).
HAQ, Health Assessment Questionnaire; PASS, Patient Acceptable Symptom Scale.